Drug Information

Drug General Information
Drug ID
D0R1FR
Former ID
DNC014131
Drug Name
(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530551]
Formula
C14H16N2
Canonical SMILES
CC1CCC2=C(C3=CC=CC=C3N=C2C1)N
InChI
1S/C14H16N2/c1-9-6-7-11-13(8-9)16-12-5-3-2-4-10(12)14(11)15/h2-5,9H,6-8H2,1H3,(H2,15,16)/t9-/m1/s1
InChIKey
WVQOYPIATZDPLZ-SECBINFHSA-N
PubChem Compound ID
11275885
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [530551]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 530551Eur J Med Chem. 2010 Feb;45(2):526-35. Epub 2009 Nov 10.Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones.
Ref 530551Eur J Med Chem. 2010 Feb;45(2):526-35. Epub 2009 Nov 10.Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.